Product Liability Archive » March, 2013

Product Liability - March, 2013

366 articles

• FDA Greenlights J&J's Controversial Diabetes Drug
• No Joke: 7 Strange-But-True Suits For April Fools'
• Whirlpool Again Urges High Court To Take Mold Case
• Firm Hit With $1M Malpractice Suit Over Hotel Stabbing Case
• Class Claims Gutted In Atty Bathroom Spying Case
• Sunland Sued Over Salmonella-Tainted Peanut Butter
• Jury Awards $20M To Bulldozer Accident Victim
• Pfizer Can't Shake Securities Action Over Celebrex Risks
• Texas High Court Limits Repair Agreement Implied Warranty
• Louisiana-Pacific Can't Reverse Class Cert. In Siding Suit
• NYC 'Soda Ban' Battle Bubbles Up To Appeals Court
• DePuy Hip Implant Patient Tells Jury Of Pain After Surgeries
• Pa. Bill Would Limit HVAC Companies' Mold Liability
• Reinsurer Says AIG Should Lose Asbestos Claims Coverage
• Generic Darvocet Cos.' Mass Action Jurisdiction Claim Denied
• Allergan Drops Patent, Ad Claims Over Eyelash Drug Latisse
• Arizona Iced Tea Skirts 'All Natural' Fraud Suit In Calif.
• Q&A With Quarles & Brady's Mark Kircher
• Reading The Labels Of Par And Harkonen
• Rule 12(e): What Is It Good For? Absolutely Nothing
• Ford Hit With Acceleration Defect Class Action
• Airlines In 9/11 Suit Defend Reduced-Damages Claim
• Whirlpool Hit With $750M Suit Over Ohio Park Chemicals
• Product Makers Stand To Profit From Pa. Tort Law Change
• Missing Witness Jury Instruction Was Improper, NJ Court Says
• Texas Attorney Stole Pfizer Settlement, Ex-Clients Say
• Alexion Gets FDA Warning Over Contamination At RI Plant
• Husband Recounts Constant Pain At DePuy Hip Implant Trial
• EPA Kicks Off Safety Reviews For Flame Retardants
• Texas Condo Owners Hit Metals USA With Defective Roofs Suit
• 6th Circ. Strikes Down Challenge To Truck Safety Rules
• New MS Drug Approved By FDA Despite Teva's Opposition
• NHTSA Slammed Over Plan To Ramp Up Rulemaking Process
• Government Didn't Cause Liquor Store Death, 6th Circ. Says
• Regulators Urged To Halt Tar Sands Pipeline Projects
• Georgia-Pacific Sued Over Rotting House Trim
• Condo Board Slapped With $40M Suit Over Verizon Antennas
• Appeals Court Sends Honda Financing Suit To Arbitration
• W.Va. AG's Pill Mill Suit Kicked Back to State Court
• Q&A With Day Pitney's James Rotondo
• Litigation Support At A Crossroads
• 9th Circ. Daubert Ruling Could Weaken Court's Gatekeeper Role
• Ala. School District Slaps BP With Deepwater Suit
• In Engle Suits, Home Court Advantage Hinges On 11th Circ.
• High Court's Comcast Ruling Raises Bar For Class Actions
• Fla. Judge Nixes Punitive Damages In Novartis Zometa Row
• NFL Commish Avoids Deposition In Super Bowl Ticket Suit
• Lawyers Weigh In On Supreme Court's Comcast Ruling
• SC Appeals Court Tosses $2.4M Verdict Against Nissan
• Wal-Mart, Panasonic Block Remand Of Shoddy Plasma TV Suit
• 'Faulty' Jail Construction Warrants No Coverage, 3rd Circ. Says
• Carnival Asks 11th Circ. To Keep Shipwreck Suit Out Of US
• Pfizer Settles Suit Over Rimadyl Dog Death
• Food Safety Group Demands Deadlines For FDA Rules
• USDA Can Overrule Courts On GE Crops Under Spending Bill
• Walgreen, Insurer End Avastin Eye Injury Coverage Suit
• Q&A With Buchanan Ingersoll's Samuel Braver
• High Court Sides With Comcast In Antitrust Class Action
• Ecuadoreans Can't Boot Special Masters In $19B Chevron Row
• Doc Gets 6 Years, To Pay $4.5M For Fen-Phen Settlement Fraud
• Flying Into Greater Uncertainty Of FAA Preemption
• National Union Off Hook In $49M Carbon Black Row: 5th Circ.
• Pom Doesn't Apply To Smucker False Ad Case, Judge Says
• Crop Dusters Don't Owe Fees To Herbicide Co., 8th Circ. Says
• Human Genome, GSK Dodge Lupus-Drug Suicide Suit
• Volvo Buyers Score Class Cert. In Sunroof Defect Suit
• Dial Can't Wash Away Antibacterial Soap Marketing MDL
• The 5 Litigators Sure To Drive Judges Mad
• Grand Jury Probe Sought In NECC Meningitis Outbreak
• Joining US, EU Probes Diabetes Drugs' Safety
• J&J Recalls 1.9M Blood Glucose Meters
• Spray Foam Companies Fight MDL Bid As Litigation Heats Up
• Trader Joe's Accused Of Covering Up Sugar Content
• DePuy Worker Warned Of Hip Design Problems, Jury Hears
• Dole Gets Claims Cut From 'All Natural' Labeling Suit
• Actos 'Most Substantial' Factor In Man's Cancer, Doc Testifies
• 9th Circ. To Rehear Mill Worker's $9.4M Mesothelioma Case
• Exxon Slapped With $1.7M Fine Over Yellowstone Oil Spill
• Q&A With McCarter & English's Michael Kelly
• What Food Cos. Can Learn From Horses And Peanuts
• US, CVR Unit Ink $2.3M Deal Over Kan. River Oil Spill
• 5 Tips For Making It Rain
• White House Weakened Food Safety Rule, Docs Show
• Ameron Knew Of Energy Project's Corrosion, AIG Unit Says
• Primary Health Gets $9.6M In Hudson Coverage Row
• Okla. Device Ruling Puts Other Products In Crosshairs
• Don't Let BP Lay All Deepwater Blame On Halliburton, US Says
• Plaintiffs Attys Say Sky's Not Falling After CAFA Ruling
• TIG Dodges AIU's $23M Asbestos Reinsurance Claim
• NJ Panel Refuses To Revive Fosamax 'Jaw Death' Suit
• High Court Seeks US Stance On Pom's Coca-Cola Label Row
• Lasik For Farsightedness Not Illegal Experiment: 9th Circ.
• FDA Challenges Execution Drug Ban In DC Circ.
• Hotel Franchisor Owed Death Suit Coverage, 11th Circ. Says
• DePuy Hip Implants Appeared To Be Safe, Surgeon Testifies
• Pa. Appeals Court Can't Tag AIG With $1.5M Gas Settlement
• Chelsea Hotel Tenants Force Delay In Renovations
• AIG Unit To Pay $2M Over Sales Tactics On Travelocity Sites
• Q&A With Hughes Hubbard's Diane Lifton
• NY's New Test For Unifying Disparate Claimants' Injuries
• CPSC Risks Alienating Industry With Litigation Strategy
• CleanWell Maker Wants Germ Killing Ad Action Wiped Out
• Force-Fed Foie Gras Suit Lacks Legal Issue, Calif. Judge Says
• BP Cries Foul Over Delayed Halliburton Cement Samples
• Doc Testifies DePuy Hip Implant Debris Caused Bone Damage
• House Bill Aims To Limit Oxycodone Prescriptions
• Supreme Court Tames Class Action Frankenstein's Monster
• Doc Testimony Over Discontinuing NuvaRing Axed From MDL
• Toyota, Plaintiffs Clash Over Future Of Acceleration MDL
• MLB Says Clinic Hurt League By Hawking Drugs To Players
• NJ Pol Pushes Sunshine Law To Limit Public Hazard Injuries
• Dole Dupes Buyers With Bogus 'All Natural' Labels, Suit Says
• FDA Wants Tougher Scrutiny Of Emergency Defibrillators
• Q&A With Kaye Scholer's Pamela Yates
• Steel Cos. Can Go After Predecessor For Site Cleanup Costs
• Boat Operator Can't Shift $25M Oil Spill Bill To Cleanup Cos.
• Ill. Keeps It Plain In Absolute Pollution Exclusions
• Ins And Outs Of Nonparty Discovery In Texas Arbitration
• Ky. Disbars Stanley Chesley Over $200M Fen-Phen Settlement
• Bayer Contests Consolidation Of Mirena IUD Defect Cases
• Philip Morris, Altria Shake 'Light' Cigarette Ad Claims
• EPA Sued Over Mass Die-Offs Of Honeybees
• CPSC Chair Backs Consumer Database Targeted By Lawsuit
• J&J Misled On Viactiv's Vitamin D Content, Suit Says
• AstraZeneca Pushes DC Circ. To Stretch Seroquel Exclusivity
• House Panel Head Delays Vote On Asbestos Trust Reform
• Target False Ad Suit Over Pollen-Free Honey Doesn't Stick
• Va. Gov. Signs Nation's 1st Biosimilar Substitution Law
• Viking Gets Defective Appliance Class Decertified
• 2nd Circ. Flips Scottsdale Win In Faulty Pool Defense Suit
• DC Circ. Blasts DEA Shipping Ban On Walgreen Facility
• Q&A With Covington & Burling's Paul Schmidt
• Philly Toyota Dealer Must Pay $16M For Rental Car Crash
• GOP Wins Promise Of Light Medical App Regulation From FDA
• 7 Reasons To Do Pro Bono Work
• Sanofi Investors Win Class Cert. In Obesity Drug Suit
• Stryker Can't Shake Hip Device Class Action
• BP Contractor M-I Escapes Deepwater Trial In 4th Week
• WTC Owners Rip Airlines' Reduced-Damages Bid In 9/11 Case
• 'Act Of War' Defense Frees American Airlines From 9/11 Suit
• Obama Plans To Max Out CPSC Commissioner Picks
• FDA, Tobacco Cos. Destined To Refight Graphic Warning War
• NYC Gears Up For Free-Speech Fight With Big Tobacco
• Evanston Dodges Coverage For Chinese Drywall In 4th Circ.
• Saudis Should Pay For 9/11, Firms Tell 2nd Circ.
• Bills Would Tighten Hydrocodone Dispensing Restrictions
• FDA Warnings Over Eye Infections Spark Partial Avastin Recall
• General Dynamics, Alliant Duck Machine Gun Glitch Suit
• Insurers Need Policyholder OK For Bad Faith Suits: Court
• Judge Says Pa. Drilling Lawsuit Settlement Is Public Record
• Q&A With Seyfarth Shaw's Jay Connolly
• Keep Watch Of French Authority's Pharma Sector Inquiry
• Avoid The Top 10 Pitfalls In A Jury Charge Conference
• Bayer Pays $24M To Settle Yaz, Yasmin Gallbladder Cases
• High Court's CAFA Ruling Carries Dangers For Defendants
• Class Action Lawyers React To Supreme Court's CAFA Ruling
• Kan. Judge Not Needed For Hot Fuel Trials, 9th Circ. Says
• High Court Urged To Bar Fees For Untimely Vaccine Claims
• Ford Assails Asbestos Suit Mistrial In Pa. Appeals Court
• Bayer, Merial Fetch Win In Flea Medication MDL
• FDA Selects Interim Director For Office Of Generic Drugs
• Supreme Court Weighs Future Of Generic-Drug Defect Suits
• Feds Slam KBR's Bid For Help Against Toxic Exposure Suits
• Lululemon Pulls See-Through Workout Pants From Shelves
• Affymax Mulls Bankruptcy After Anemia Drug Recall
• Q&A With Dechert's William Oxley
• Derailment Spill Suit Belongs In Federal Court, Conrail Says
• Nintendo Takes Faulty Wii Controller Row Into Arbitration
• Justices Restore Class Action Fairness Act's Removal Power
• And Now A Word From The Panel ...
• FDA Approval Preempts DePuy Knee Device Suit, Judge Says
• Ticketmaster's $23M Coupon Settlement Stalls Over Attys' Fees
• Cephalon Hit With FCA Suit Over Off-Label Marketing
• Barnes & Thornburg Snags Litigation Ace From Calif. Firm
• AT&T U-Verse Class Action Deserves Trial, High Court Told
• Compounder Recalls All Products After Mold Found
• FDA Recommends Postponing Abbott MitraClip Approval
• High Court Snubs 3rd-Party Appeal By 'Popcorn Lung' Expert
• RJ Reynolds Asks 2nd Circ. To Snuff Ex-Smoker's $24M Verdict
• FDA Told To Improve Complaints Tracking For Supplements
• Mistrial Declared In Merck's 1st Fosamax Femur Trial
• BP Can't Shake Threat Of $17B Deepwater Fines
• Symantec Inks $11M Deal Ending Claims It Used Scare Tactics
• Bloomberg Pushes For Tobacco Display Ban In NYC
• Q&A With Adams and Reese's Lee Butler
• Current Trends In FDA's Good Manufacturing Enforcement
• What Litigators Must Know About Va.'s 'Rocket Docket'
• Chiquita Terrorist Ruling Vexes Cos. Accused Of Negligence
• MDL Judge Limits Medical Fee Claims In 46 Novartis Suits
• Engle Ruling Leaves Tobacco Cos. With Dwindling Options
• NRDC Can Sue Over Antibacterial Soap Regulation: 2nd Circ.
• West-Ward Lobs $175M False Ad Suit At Generic-Drug Rivals
• Insurers, NFL Can Fight Concussion Suit Coverage In NY
• Abbott Escapes Ensure Drinker's False Ads Suit
• Patton Boggs Must Cough Up Docs In Chevron Pollution Saga
• Q&A With Alston & Bird's Lisa Gilford
• Toyota Can't Beat Suit Over Lexus Headlight Problems
• We Need More Diversity In Mediation
• FDA Says It Caved To Politics In Clearing ReGen Implant
• C.R. Bard Ducks FCA Suit Over Catheter Kickbacks
• Fla. High Court Declines To Revisit Engle Decision
• FDA Warns Fresenius Medical Over Dialysis Device
• Rising Star: Kaye Scholer's Angela Vicari
• Appeals Court Says Economic Loss Rule Bars Damages Claim
• Tobacco Cos. Evade Law With Color Branding, Study Finds
• Late Notice Tougher For NJ Tort Plaintiffs In Gov't Suits
• AIG Seeks To Trim Coverage Suit Over WTC Asbestos Claims
• FDA Generic-Drug Leader Steps Down Amid Agency Changes
• FDA Will Probe Diabetes Drug Safety Risk Report
• Ark. Gets $23M Boost Following End Of Tobacco MSA Dispute
• Carnival Knew 'Poop Cruise' Ship Had Problems, Suit Says
• BMW Hit With Mini Cooper Engine Defect Class Action
• Criminal Probe Drives Deepwater Atty From Plaintiffs Team
• 2nd Circ. Frees St. Paul From Phone Card False Ad Coverage
• Q&A With Covington & Burling's Michael Imbroscio
• Apple's Shoddy Retina Displays Fool Consumers, Suit Says
• Honda Pulls 180K SUVs, Sedans Over Braking Defect
• E-Discovery Trends: Looking Back To Move Forward
• BASF, Shell Reach $315M Deal In Brazil Pesticide Row
• NY Soda Ruling May Scare Off Other Health Edicts
• Lawmakers, Attys Feud Over Costs Of Asbestos Disclosure Bill
• MoFo Snares Consumer Class Action Pro From Paul Hastings
• BP Bets Big On Covington's Mike Brock In Oil Spill Trial
• Union Pacific Wants AIG, Argo To Foot Train Crash Settlement
• Endo Medical Mesh Suit Booted Back To Calif. Court
• Rising Star: Sidley Austin's Kara McCall
• Insurer Disputes Duty To Defend In Drug Co.'s Pill Mill Suit
• FDA Can Regulate Stem Cell Treatment As Drug, DC Circ. Hears
• 6th Circ. Says Pliva Failure-To-Warn Claims Not Preempted
• Facebook Gag Lifted For Atty Who Dissed McDonald's Deal
• Philip Morris Wants Class Cert. Bid Smoked In 'Light' Cig Suit
• Q&A With Seyfarth Shaw's Shawn Wood
• The Outer Limits Of Expert Testimony Gatekeeping
• FAA OKs Boeing Testing Plan For Grounded Dreamliners
• General Mills Says False Ad Case Best Left To FDA
• Stryker Warned By FDA For Marketing Of Recalled Device
• Obesity Danger From Sugary Drinks Key In 'Soda Ban' Appeal
• Merck's Fosamax Caused Femur Fractures, Jury Hears
• Pa. Lawmaker Eyes 15-Year Limit On Product Liability Suits
• Pa. Sen. Pushes Genetically Engineered Food Label Bill
• Waiora Pays $12M To Settle Suit Over Anti-Aging Supplement
• Revised Audi Transmission Settlement Gets Judge's OK
• Kline & Specter Sues 2 Firms Over GSK Dental Cream Deals
• Pfizer Antibiotic Linked To Deadly Heart Disorder, FDA Warns
• Pa. Rep. Seeks Disclosure Of Pipelines' Impact On Neighbors
• Pella Puts Up $90M To Settle Window Defect Class Action
• Q&A With Latham & Watkins' Gwyn Williams
• Rising Star: Greenberg Traurig's Robert Herrington
• Supreme Court Hearing Sought For Katrina Levee Breach Case
• A Bitter Loss For POM Signals More FTC Scrutiny
• Pfizer Deal Marks A Missed Chance For Branded-Drug Cos.
• AIG Wins State Venue For Asbestos Reinsurance Fight
• Patton Boggs Can't Tap $22M Chevron Pollution Bond
• CORRECTED: Insurer Says Cracked Security System Led To $80M Lilly Theft
• NFL Moves For Sanctions In Super Bowl Ticket Dispute
• State AGs Push For Abuse-Resistant Generic Painkillers
• Alaska Village Asks High Court To Mull Climate Change Suit
• Weyerhaeuser Seeks Defense Coverage Of 130 Asbestos Suits
• 6th Circ. Says $3B Dow Deal Requires Authorization Of Credits
• NY Judge Crushes Bloomberg's 'Arbitrary' Large-Soda Ban
• Altria Urges 2nd Circ. To Rethink NYC Flavored Tobacco Limits
• High Court Asked To Hear Generic Reglan Design Defect Suit
• EU Imposes Full Ban On Animal-Tested Cosmetics
• 3rd Circ. Won't Revive NJ Gas Co.'s Faulty Valve Suit
• Q&A With Patterson Belknap's John Winter
• Rising Star: Latham & Watkins' Art Foerster
• Getting The Wrinkles Out Of Anti-Aging Products
• Rising Star: Reed Smith's Tracy Gregar Ferak
• Federal Asbestos Trust Bill Takes Forum-Shopping Off Table
• J&J Recalls K-Y Lubricants To Skirt FDA Review
• 9th Circ. Revives Juicy Juice Brain Development Claims
• BP Oil Spill Judge Forges New Path For MDLs
• 5-Hour Energy Maker Faces Class Action Over 'Crash' Claims
• FDA's New Safety Reports Raise Tort Risks For Device Cos.
• Muscle Milk Maker Inks $5.3M False Ad Settlement
• Sanofi Facing DOJ Investigation Over Plavix Disclosures
• General Dynamics To Face New Trial Over Fatal Explosion
• Barr, Travelers Settle Benzene-Exposure Coverage Dispute
• USDA Releases Meat Labeling Changes After WTO Loss
• Contractors Front $21M To Settle O'Hare Rehab Dispute
• Law360 Names Top Attorneys Under 40
• 3rd Circ. Tosses Brother Fraud Suit For Relying On NJ Law
• Rapid-American Enters Ch. 11 To Handle Asbestos Claims
• BP To Pay Much More Than $7.8B In Deepwater Deals
• DePuy Hit With $8.3M Verdict Over Metal Hip Implant
• Aetna Sued Over Personal Injury Benefit Repayments
• FDA Urges More Accuracy On 'Latex Free' Med Supply Labels
• Warner Chilcott Misbranded Drugs, FCA Kickback Suit Says
• Q&A With Morgan Lewis' James Pagliaro
• Duration Of Damages: Can Lost Profits Continue Forever?
• Minn. Ruling Saps Power Of Genetic Links In Food Suits
• Fla. High Court Limits Tort Claims Doctrine In Marsh Suit
• Halliburton, BP Used Bad Cement In Macondo Well: Expert
• Transit Agency Shakes Pa. Railroad Bridge Defect Suit
• Pa. Appeals Court Tosses Paxil Birth Defect Suit
• Whistleblower Can Pursue FCA Suit Over Vascular Treatments
• Ill. Appeals Court Holds Asbestos Insurers To 'All Sums'
• Q&A With Paul Weiss' Craig Benson
• DaVita HealthCare Hit With Suits Over Dialysis Deaths
• EU Food Business Operators Still Have A Lot To Chew Over
• Affymax Sued Over $500M Stock Drop Linked To Recall
• Ecuadoreans Want Judge Kaplan Off Of $19B Chevron Dispute
• Food Cos. Likely To Embrace Wider Tracing, On One Condition
• 8th Circ. Says Alcoa Injury Plaintiff Can't Switch Venues
• Teva's Defective IUD Caused Injuries, $15M Suit Says
• Macondo Workers Broke With Oilfield Practices, Expert Says
• Pa. High Court Mulls Expert Affidavits In Asbestos Case
• Ranbaxy Ducks Wider Recall In Glass Particles Class Action
• Casino Patron Awarded $1.4M For Elevator Shaft Fall
• $200M Tobacco Funds Aren't For Pa. Coffers: Appeals Court
• Insurer Denies Defense Duty In Mine Safety Gear Suits
• DynCorp Dodges Ecuadoreans' Chemical-Exposure Suit
• Q&A With Dechert's Ben Barnett
• More FDA Detention Slips For Food Cos.
• Chicago City Council Mulls Ban On Energy Drinks
• Ex-BP Exec Says Congress Obstruction Charge Can't Stand
• Deepwater Blast Survivor Says Workers Missed Warnings
• FDA Says Hospira Plant Continues To Have Quality Issues
• Facing Outcry, FDA Alters Comment Period On FSMA Rules
• FDA Again Delays Expanded Use Of Blood Thinner Xarelto
• Pfizer Beats Medicare Fraud Suit Over Pain Patch Marketing
• GSK, Thalidomide Plaintiffs Spar Over Pa., Federal Jurisdiction
• Express Scripts Says Class Action's Recall Bid Hits FDA Turf
• Locke Lord Adds Chicago Litigation Pro
• Impax Still Needs To Fix Production Plant Issues, FDA Says
• Par To Pay $45M For Off-Label Marketing Of AIDS Drug
• Fen-Phen Claimant Wrongly Denied Benefits, 3rd Circ. Told
• SNR Denton Adds 5 Gordon & Rees Attys In San Francisco
• Q&A With King & Spalding's Andy Bayman
• Sharpen Your Pencils For Conflict Minerals Disclosures
• Calif. Agency's BPA Debate May Boost Chemical Cos.' Suit
• Garlock Wins Access To Asbestos Bankruptcies On Appeal
• BP's 5th Circ. Win Heats Up $750M Transocean Coverage Row
• House GOP Fears ACA's Device Tax Could Hit Smartphones
• BP Didn't Probe Deepwater Cost-Cutting Risks, Safety VP Says
• Novartis Hit With $250K Verdict In Zometa Jaw Injury Suit
• Miami Luxury Condo Board Sues Builders For Negligence
• Pa. Lawmaker Aims To Publicize Fracking Water Test Results
• Crane, Others Owe $35M For Asbestos Death, Jury Says
• XL, Ace Off The Hook For $850M Seroquel Defense Costs
• J-M Can't Dodge FCA Suit Over Defective Pipes
• Novartis Gets NJ Damages Applied To Fla. Bone Drug Suit
• Zimmer, Marketing Co. Win New Trial In Knee Injury Case
• Conrail Fires Back Against Derailment Exposure Suit
• Roche Appeals Recusal Ruling In NJ Accutane Suits
• 2nd Circ. Says NY County Can't Recover Plane Crash Costs
• Depositions In $19B Chevron RICO Suit Will Be Refereed
• Aon Says Litchfield Brokered Subpar Policy For Contractors
• BP Can Tap $750M Transocean Insurance, 5th Circ. Says
• Q&A With Hogan Lovells' Lauren Colton
• Best Practices Of Conducting An Accident Investigation
• Patton Boggs Forced To Lay Off 65 As Work Dries Up
• P&G, Kimberly-Clark Released From Defective Diaper FCA Suit
• Transocean, Halliburton Say BP Should Pay Deepwater Costs
• Merck To Kick Off 2nd Round Of Fosamax Suits In NJ
• Reinsurer Sues Over AIG's $262M Asbestos Coverage Claim
• Lance Armstrong Endorsements Founded On Lies, Class Says
• FDA's Facebook Slap Gives Drug Industry Little To Like
• Worker-Caused Injuries Must Be Covered: Calif. Appeals Court
• Pa. High Court May Demand More From Asbestos Experts
• Sears Fights Washer-Defect Class Cert. In High Court Appeal
• Roche Inches Closer To Escaping Accutane MDL
• Q&A With Robins Kaplan's Brad Engdahl
• Pilgrim's Pride Exposed Workers, Families To Staph: Suit
• Sheppard Mullin Adds Squire Sanders Litigation Pro In SF
• NY Cedents Enjoy More Protection And Authority